T. Saridogan Et Al. , "Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer," Scientific Reports , vol.13, no.1, 2023
Saridogan, T. Et Al. 2023. Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific Reports , vol.13, no.1 .
Saridogan, T., Akcakanat, A., Zhao, M., Evans, K. W., Yuca, E., Scott, S., ... Kirby, B. P.(2023). Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific Reports , vol.13, no.1.
Saridogan, Turcin Et Al. "Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer," Scientific Reports , vol.13, no.1, 2023
Saridogan, Turcin Et Al. "Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer." Scientific Reports , vol.13, no.1, 2023
Saridogan, T. Et Al. (2023) . "Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer." Scientific Reports , vol.13, no.1.
@article{article, author={Turcin Saridogan Et Al. }, title={Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer}, journal={Scientific Reports}, year=2023}